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Abstract
Panton-Valentine leukocidin (PVL) is a cytotoxin secreted by Staphylococcus aureus and associated with severe necrotizing
infections. PVL targets polymorphonuclear leukocytes, especially neutrophils, which are the first line of defense against
infections. Although PVL can induce neutrophil death by necrosis or apoptosis, the specific inflammatory responses of
neutrophils to this toxin are unclear. In this study, both in vivo and in vitro studies demonstrated that recombinant PVL has
an important cytotoxic role in human neutrophils, leading to apoptosis at low concentrations and necrosis at high
concentrations. Recombinant PVL also increased the levels of pro-inflammatory cytokine secretion from neutrophils. The up-
regulation of pro-inflammatory cytokines was due to nuclear factor-kappa B (NF-kB) activation induced by PVL. Moreover,
blocking NF-kB inhibited the production of inflammatory cytokines. To test the role of neutrophil immune responses during
the pathogenesis of PVL-induced acute lung injury, we used immunocompetent or neutropenic rabbits to develop a model
of necrotizing pneumonia. Immunocompetent rabbits challenged with PVL demonstrated increased inflammation
containing neutrophilic infiltrates. In addition, there were elevated levels of inflammatory cytokines (IL-6, IL-8, TNF-a and IL-
10) and NF-kB in the lung homogenate. In contrast, the lung tissues from neutropenic rabbits contained mild or moderate
inflammation, and the levels of inflammatory cytokines and NF-kB increased only slightly. Data from the current study
support growing evidence that neutrophils play an important role in the pathogenesis of PVL-induced tissue injury and
inflammation. PVL can stimulate neutrophils to release pro-inflammatory mediators, thereby causing an acute inflammatory
response. The ability of PVL to induce inflammatory cytokine release may be associated with the activation of NF-kB or its
pore-forming properties.
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Introduction
Staphylococcus aureus infections are increasingly common in the
general population and can cause serious infectious diseases, from
skin and soft tissue disease to fatal infections [1]. The virulence and
relatively facile transmission of S. aureus make it a dangerous
pathogen and a cause for increased concern. Among several
putative determinants of S. aureus virulence, Panton-Valentine
leukocidin (PVL) is the key toxin and is associated with increased
risk of transmission, complications and hospitalization [2]. PVL is
a b-barrel pore-forming protein that creates an octamer structure
essential for pore formation on host cells [3–4]. Both human and
rabbit neutrophils are highly sensitive to the pore-forming
properties of PVL and rapidly undergo cell death.
Compared with PVL-negative S. aureus isolates, PVL-positive
isolates are generally more virulent and typically occur in
community environments [5–6]. S. aureus virulence is increasing
worldwide and it has become the main cause of severe necrotizing
diseases, such as necrotizing pneumonia, severe sepsis and severe
skin infections [7–9]. Owing to the severe infections caused by
PVL-producing S. aureus, isolates with high morbidity and
mortality rates have arisen despite antibiotic use [10–11].
The mechanisms of how PVL may cause tissue injury in
necrotizing diseases are unknown. One possibility is that PVL can
induce lysis of polymorphonuclear leukocytes resulting in impaired
host defense. This would interfere with the clearance of pathogenic
organisms and allow further bacterial growth and the increased
expression of tissue-damaging exotoxins [2]. However, a recent
study indicated that PVL-induced acute lung injury was
independent of bacterial survival or replication in the lung [12].
Thus, antibiotic treatments do not significantly reduce mortality. A
previous study demonstrated that specific antibodies to LukS-PV
(a protein secreted by the PVL gene) induced by intranasal or
subcutaneous vaccination could protect animals against acute
infection and reduce inflammation [13]. Therefore, PVL may
activate target cells to release excessive levels of inflammatory
cytokines that may cause acute uncontrolled inflammation and
tissue injury [2,12,14]. Using microarray profiling and biochem-
ical studies, Zivkovic et al [15] showed that PVL can induce highly
specific inflammatory transcriptional responses in alveolar macro-
phages. However, the effect of PVL on the production of
PLoS ONE | www.plosone.org 1 April 2012 | Volume 7 | Issue 4 | e34970inflammatory cytokines in neutrophils is unclear. Therefore, this
study investigated the detailed functions and mechanisms of PVL-
induced inflammatory cytokine production in neutrophils.
Materials and Methods
Ethics statement
Taking of blood samples from humans as well as cell isolation
and animal experiments were approved by the local ethics
committee (Ethics Committee of the Anhui Provincial Hospital).
Human blood samples were taken from healthy volunteers, who
provided written informed consent for the collection of samples
and subsequent neutrophil isolation. All animals were handled in
strict accordance with the recommendations of the Weatherall
report, and animal keeping, endotracheal instillation and killing
were supervised with the help of the Animal Experiment Center of
Anhui Provincial Hospital.
Table 1. Specification of primers used in RT-PCR.
Target gene Primer Sequence 59—39 Length of production
TNF-a S: 59 GTCGGTCACCCTTCTCCA 39 18 524 bp
A: 59 CAGCCTCTTCTCCTTCCT 39 18 524 bp
IL-8 S: 59 ACATACTCCAAACCTTTCCACCC 39 23 175 bp
A: 59 CAGCCCTCTTCAAAAACTTCTCC 39 23 175 bp
IL-6 S: 59 GTCCAGTTGCCTTCTCCC 39 18 223 bp
A: 59 GCCTCTTTGCTGCTTTCA 39 18 223 bp
IL-10 S: 59 ATGCACAGCTCAGCACTGCTCTG -39 23 448 bp
A: 59 GGAAGAAATCGATGACAGCGCCG -39 23 448 bp
b-actin S: 59 GGGACCTGACTGACTACCTC 39 20 546 bp
A: 59 ACTCGTCATACTCCTGCTTG 39 20 546 bp
doi:10.1371/journal.pone.0034970.t001
Figure 1. Neutrophil apoptosis and necrosis as a function of the rPVL concentration. Neutrophils were incubated with PBS, 5 nM/L rPVL
and 100 nM/L rPVL for 5 h and then observed by (A) phase contrast microscope, (B) biological microscope, or (C) transmission electron microscopy.
doi:10.1371/journal.pone.0034970.g001
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The pET28a vector (Roche Diagnostics Corp., Switzerland) was
used to produce recombinant 6 His-tagged LukS-PV and LukF-
PV proteins (the two components of PVL). The sequence was
amplified from PVL-positive S. aureus isolates using the following
primers, close to the coding region of LukF-PV and LukS-PV:
LukF-FW (59-acgcGGATCCGCTCAACATATCACACCTG-
TAAG-39), LukF-RV (59-accgCTCGAGTTAGCTCATAGGAT-
TTTTTTCCTTAGATTG-39), LukS-FW (59-acgcGGATCC-
GAATCTAAAGCTGATAACAATATTGAGAATATTG-39),
and LukS-RV (59-accgCTCGAGTCAATTATGTCCTTTCAC-
TTTAATTTCATGAG-39). PCR products were digested with
XhoI and BamH I (Promega, Madison, WI, USA) and ligated into
pET28a. Respective LukF-pET28a and LukS-pET28a constructs
were transformed into Escherichia coli DH5a (Invitrogen, Carlsbad,
CA, USA), and clones were verified by DNA sequencing. BL21
(DE3) pLys (Invitrogen) were used for expression of pET28a
plasmids for 6 h following induction with 0.1 mM isopropyl-b-D-
thiogalactoside (Promega). The fusion proteins (6His-LukS-PV
and 6His-LukF-PV) were purified by His?Band Purification Kit
(Novagen, Darmstadt, Germany) according to the manufacturer’s
instructions. Finally, proteins were subjected to LPS removal using
DetoxiGel columns (Thermo Scientific) until a final LPS
concentration of ,0.02 EU/ml was ensured.Purity of the fusion
proteins were checked by western blot. LukS and LukF were
stored at 220uC. Both subunits were mixed at equimolar ratios
immediately before addition to cells or rabbits.
Neutrophil cell isolation
Human neutrophils were isolated from peripheral blood of
healthy volunteers with their informed consent and with the ethics
committee of the Anhui Provincial Hospital approval. Neutrophils
were isolated by dextran sedimentation and centrifugation using
Polymorphprep (TBD Co., China), according to the manufactur-
Figure 2. Effect of rPVL on cytokine secretion. 1, control; 2, treated with 5 nmol/L rPVL for 5 h; 3, treated with 100 nmol/L rPVL for 5 h. The
supernatants of neutrophils were collected and IL-6 (A), IL-8 (B), TNF-a (C), IL-10 (D) secretion was measured by ELISA. Results represent the mean 6
SD of three separate measurements. * P,0.05.
doi:10.1371/journal.pone.0034970.g002
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cell pellet with an ice-cold isotonic NH4Cl solution (155 mM
NH4Cl, 10 mM KHCO3, 0.1 mM EDTA, pH 7.4). Cell viability
was assessed using the trypan blue exclusion method and a
viability of 94% or more was used for experiments. In all cases, cell
purity was above 95% as observed following May-Gru ¨nwald and
Giemsa staining.
Cell culture and rPVL challenge
Purified neutrophils were cultured in RPMI 1640 culture
medium (Gibco-BRL, Gaithersburg, MD, USA) supplemented
with 10% heat-inactivated FCS (Gibco-BRL), 100 U/ml penicil-
lin, and 100 mg/ml streptomycin. Twenty-four hours before
treatment, cells were seeded into tissue culture plates in triplicate.
At the time of treatment, culture medium was replaced with fresh
RPMI 1640 containing PBS, 5 nmol/L rPVL or 100 nmol/L
rPVL respectively, according to the methods described previously
[12,15–16]. For the NF-kB inhibitor assays, isolated neutrophils
were further divided into 3 groups designated as group A, B and
C. Cells in group A were treated with PBS as a negative control.
Cells in group B were directly treated with 100 nmol/L rPVL for
2 h. Neutrophils in group C were pretreated with PDTC
(Invitrogen) for 1 h, a potent inhibitor of NF-kB, before the
addition of experimental stimuli.
Observation of cell morphology
After rPVL treatment, the morphology of neutrophils from
different groups was observed using a phase contrast microscope
(Nikon, Tokyo, Japan). Cells were then collected and examined for
morphologic changes by Wright and Giemsa staining using a
biological microscope (Nikon). The ultrastructure of PVL- treated
neutrophils was examined by transmission electron microscopy.
ELISA
The amount of cytokines (IL-6, IL-8, IL-10 and TNF-a)
released from the culture medium of cells and lung tissue
homogenate were determined using specific ELISAs (R&D
Systems, Minneapolis, MN, USA) in accordance with the
manufacturer’s instructions.
Reverse-transcription (RT) polymerase chain reaction
(PCR)
Total RNA extracted from neutrophils were reverse-transcribed
for 1 h at 42uC with AMV reverse transcriptase, followed by PCR
analysis using the primers as described below (Table 1). During
analysis, the amplified transcripts of b-actin were used as an
internal control.
Western blot
Nuclear proteins (NF-kB P65) were extracted using the Nuclear
Protein Extraction Kit (BestBio Corp., Shanghai, China), in
accordance with the manufacturer’s instructions. The concentra-
tion of extracted protein was determined using the BCA method.
Western blotting was performed as described previously [12].
Mouse anti-NF-kBp65 antibody was used at a dilution of 1:500. b-
actin antibody served as a control to confirm equal loading.
Densitometry index analysis of the bands was achieved using a gel
imaging system.
Development of the necrotizing pneumonia model in
rabbits
Rabbits were randomly divided into three groups of five rabbits
each. The immunocompetent rabbit treatment group received
25 mg rPVL as previously described [15]. The neutropenia
treatment group received two doses of vinblastine (0.75 mg/kg)
i.v. at 96 h and 48 h to induce neutropenia, and then 25 mg rPVL
was administered into the lungs. Rabbits in the control group
received 0.9% saline. All liquids were delivered directly into the
lungs of rabbits through a 2.5-mm pediatric endotracheal tube
positioned 1 cm above the main stem bronchi. Rabbits were
sacrificed at 9 h post-infection.
Histopathology
Lung tissues were harvested after 9 h post-infection, fixed in
10% formalin, and embedded in paraffin. Paraffin sections of lung
tissue were cut to 4 mm thick, and stained using hematoxylin and
eosin. Each specimen was analyzed blind by a pathologist.
Immunohistochemical staining
Immunohistochemical staining was carried out following the
manufacturer’s instructions. Briefly, following Ag retrieval and
blocking, lung sections were incubated with mouse anti-NF-kB
FITC (BD Biosciences, San Jose, CA, USA) (1:100 dilution) at
room temperature. After rinsing with PBS for 5 min, the sections
were incubated in horse-radish peroxidase-conjugated secondary
antibody. Following secondary washing, peroxidase activity was
visualized with diaminobenzidine as a chromogen. All sections
were rinsed and counterstained lightly with Harris hematoxylin.
Statistical analysis
Differences between groups were analyzed using unpaired t test
or one-way ANOVA. Values are expressed as mean6SD. A value
of p,0.05 was considered statistically significant.
Results
Recombinant PVL is a potent cytolytic toxin for human
neutrophils
The two products of pvl expression, rLukS-PV and rLukF-PV,
were incubated with neutrophils at equimolar concentrations of
5 nmol/L or 100 nmol/L for 5 h. Compared with the control
group receiving PBS, neutrophils showed typical features of
apoptosis, with rounding of cells (Figure 1A). In addition, nuclei
and pronounced chromatin condensation (Figure 1B) were
observed after treatment with 5 nmol/L rPVL for 5 h. In contrast,
5 h of treatment with 100 nmol/L rPVL induced typical necrosis
morphology, including swelling, presence of vacuoles and
karyorrhexis (Figure 1B).
The morphologic observations were confirmed by ultrastruc-
tural examination using transmission electron microscopy. Fol-
lowing treatment with 5 nmol/L rPVL, most neutrophils demon-
strated pyknotic nuclei, with a migration of nuclear chromatin,
formation of apoptotic bodies, and some vacuoles present in the
cytoplasm. In contrast, neutrophils treated with 100 nmol/L rPVL
were predominantly necrotic, with loss of cell membrane integrity
and many vacuoles present in the cytoplasm (Figure 1C).
PVL induces neutrophils to release pro-inflammatory
cytokines
As shown in Figure 2, treatment of neutrophils with 5 nmol/L
rPVL increased the levels of IL-6, IL-8 and TNF-a in the medium
from 16.7 to 23.45 mg/L, 1.8 to 14.7 mg/L, and 43.53 to
72.53 mg/L, respectively. The treatment with 100 nmol/L rPVL
resulted in 4.2-fold, 19.3-fold and 2.7-fold increases in IL-6, IL-8
and TNF-a levels respectively, when compared with the control
group (Figure 2). However, the effect of rPVL on IL-10 secretion
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PLoS ONE | www.plosone.org 4 April 2012 | Volume 7 | Issue 4 | e34970Figure 4. Expression of NF-kB p65 mRNA in neutrophils. Cells were treated with PBS (1), 5 nmol/L rPVL for 2 h (2) or 100 nmol/L rPVL for 2 h
(3), respectively. A: Representative agarose-gel photograph showing the expression levels of NF-kB p65 mRNA in polymorphonuclear cells using RT-
PCR. B: Relative levels of NF-kB p65 expressed in polymorphonuclear cells. The values indicate the expression indices of the densitometry units
relative to the amount of b-actin. Results represent the mean 6 SD of three separate measurements. * P,0.05.
doi:10.1371/journal.pone.0034970.g004
Figure 3. Expression levels of cytokine mRNA in neutrophils. 1, control; 2, treated with 5 nmol/L rPVL for 5 h; 3, treated with 100 nmol/L rPVL
for 5 h. Representative agarose-gel photographs showing the expression level of IL-6 (A), IL-8 (B), TNF-a (C) and IL-10 (D) mRNA from neutrophils by
RT-PCR analysis. The relative levels of IL-6 (E), IL-8 (F), TNF-a (G) and IL-10 (H) expressed were compared with b-actin levels. * P,0.05.
doi:10.1371/journal.pone.0034970.g003
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treatment groups (Figure 2D).
Similar to the protein secretion data, exposure of neutrophils to
5 nmol/L rPVL induced up-regulation of IL-8 and TNF-a
mRNA expression. Treatment with 100 nmol/L rPVL increased
IL-6, IL-8 and TNF-a mRNA expression by 44.1%, 74.5% and
56%, respectively (Figure 3). In contrast, no significant IL-10
expression was noted following 5 h of infection with rPVL
(Figure 3D).
PVL-induced nuclear factor-kappa B (NF-kB) is important
for pro-inflammatory cytokine synthesis
As shown in Figure 4, following treatment with 100 nmol/L
rPVL for 2 h, NF-kBp65 mRNA expression increased 3.3-fold
relative to levels in the control group (n=3, P#0.05). Western blot
analysis showed a higher expression level of NF-kB protein in
neutrophils compared with control groups (Figure 5). The mean 6
SD expression level of NF-kB protein in the control group,
5 nmol/L rPVL treatment group, and 100 nmol/L rPVL
treatment group were 0, 0.2860.07, and 1.1360.22, respectively
(P#0.05).
To establish whether NF-kB was involved in pro-inflammatory
cytokine production, neutrophils were incubated with an NF-kB
inhibitor to block its activation before rPVL treatment. Western
blot analysis demonstrated that pyrrolidine dithiocarbamate
(PDTC) reduced NF-kB activation in neutrophils treated with
rPVL (Figure 6). Enzyme-linked immunosorbent assay (ELISA)
analysis demonstrated that IL-6, IL-8 and TNF-a production
significantly decreased by 59.9%, 73.1%, and 55.9% respectively,
in the PVL-treated group compared with the PDTC-pretreated
group (Figure 7). RT-PCR analysis showed that pre-treatment
with PDTC decreased IL-6, IL-8 and TNF-a mRNA expression
induced by rPVL (Figure 8).
Figure 6. Expression of NF-kB protein in neutrophils after NF-kB inhibition. 1: Cells treated with PBS; 2: cells treated with rPVL; 3: cells
incubated with PDTC for 1 h before treatment with rPVL. A: The expression levels of NF-kB proteins in polymorphonuclear cells were analyzed by
western blot. B: Relative levels of NF-kB expressed in polymorphonuclear cells. The values indicate the expression indices of the densitometry units
relative to the amount of b-actin. Results represent the mean 6 SD of three separate measurements. * P,0.05.
doi:10.1371/journal.pone.0034970.g006
Figure 5. Expression of NF-kB protein in neutrophils. Cells were treated with PBS (1), 5 nmol/L rPVL for 2 h (2) or 100 nmol/L rPVL for 2 h (3)
respectively. A: The expression levels of NF-kB proteins in polymorphonuclear cells were analyzed by western blot. B: The relative levels of NF-kB
expressed in polymorphonuclear cells. The values indicate the expression indices of the densitometry units relative to the amount of b-actin. Results
represent the mean 6 SD of three separate measurements. * P,0.05.
doi:10.1371/journal.pone.0034970.g005
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dependent mechanism
rPVL-treated animals exhibited increased inflammation with
neutrophilic infiltrate, necrosis, diffuse alveolar hemorrhage and
pulmonary edema. Furthermore, four of five animals displayed
areas of necrosis. However, the lung tissues of neutropenic rabbits
exhibited mild or moderate inflammation, as only one of five
animals had some areas of slight necrosis (Figure 9E).
ELISA analysis demonstrated that IL-6, IL-8 and TNF-a levels
increased by 3.7-, 4.3- and 2.2-fold in the lungs of immunocom-
petent rabbits compared with neutropenic rabbits where there was
no increase (Figure 10).
The expression of NF-kB in the animal models was analyzed by
immunohistochemistry. Significant NF-kB nuclear translocation
was present in 63.4% (53/80) of neutrophils from immunocom-
petent rabbits treated with rPVL. NF-kB expression in the lung
tissues from neutropenic rabbits treated with rPVL was signifi-
cantly lower in the nucleus of cells (P,0.05) compared with the
rPVL-treated immunocompetent rabbits (Figure 11).
Discussion
A dramatic increase in the number of S. aureus infected by
bacteriophages carrying the pvl gene has triggered an intense
search for the underlying factors regarding this [17–18]. Previous
studies have assayed neutrophil lysis induced by PVL using S.
aureus culture filtrates in vitro [10,19–20]. However, predictions on
the relative contribution of PVL to necrotizing pneumonia
pathogenesis on that basis are problematic, as PVL concentrations
vary considerably depending on the growth media used [11,21].
Therefore, this study constructed, expressed, and purified
recombinant PVL (rPVL). The cytotoxic effect of rPVL was
demonstrated using human neutrophils. In our study, rLukS-PV
and rLukF-PV were incubated together with neutrophils at
equimolar concentrations of 5 nmol/L or 100 nmol/L. Compared
with the control group receiving PBS, PMNs viability decreased in
vitro, leading to apoptosis at low concentrations and necrosis at
high concentrations of rPVL. The morphologic observations were
confirmed by ultrastructural examination using transmission
electron microscopy.
Figure 7. Effect of rPVL on cytokine secretion in neutrophils. 1: Cells were treated with PBS; 2: cells were treated with rPVL; 3: cells pretreated
with PDTC for 1 h before treatment with rPVL. The supernatants of polymorphonuclear cells were collected and IL-6 (A), IL-8 (B), TNF-a (C) levels were
measured by ELISA. Results shown are representative of three independent experiments. * P,0.05.
doi:10.1371/journal.pone.0034970.g007
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sufficient to induce cell death. This finding confirmed previous
studies [2,4]. PVL can induce neutrophil death in vitro; either
apoptosis at low concentrations or necrosis at high concentrations.
The results also verify that rPVL has the same biological activity as
the native PVL protein, providing an experimental basis for the
further study of its biological functions.
Evidence from several studies suggests that a complex network
of inflammatory cytokines and chemokines play a major role in
mediating, amplifying, and perpetuating inflammation [22–23].
Regulation of pulmonary inflammation involves an intricate
balance of both pro-inflammatory and anti-inflammatory media-
tors [24–25]. Many pro-inflammatory cytokines increase lung
injury. Nevertheless, the effect of PVL on cytokine release from
neutrophils remains controversial. Previous reports suggest that
PVL can induce a continuous increase (over 16 h) of pro-
inflammatory IL-8 from human leukocytes [12,14,26]. Other
studies have reported that PVL significantly increased the
production of the anti-inflammatory cytokine IL-10 and slightly
decreased the expression of pro-inflammatory cytokines (TNF-a)
in neutrophils [27]. In contrast, Christopher et al [28] concluded
that PVL did not significantly alter the transcription of
inflammatory genes in the lung. Therefore, we investigated the
inflammatory cytokine release from neutrophils in response to
rPVL treatment. In our study, we demonstrated that treatment of
neutrophils with rPVL resulted in the gene expression as well as
protein production of IL-6, IL-8 and and TNF-a. Whereas, no
significant IL-10 expression was noted following treatment with
rPVL. These results demonstrate that rPVL can activate
neutrophils to release increased levels of pro-inflammatory
cytokines, which may cause tissue destruction.
The detailed mechanism of PVL-induced inflammatory cyto-
kine production in neutrophils is still unknown. Previous studies
have suggested that PVL induced neutrophil lysis could result in
the release of inflammatory cytokines and/or reactive oxygen
metabolites [29–30]. Using a rabbit model of necrotizing
pneumonia, Diep et al proposed that PVL could activate
polymorphonuclear leukocytes and induce cytokine secretion by
Figure 8. Expression of cytokine mRNA in neutrophils. 1: Cells were treated with PBS; 2: cells were treated with rPVL; 3: cells pretreated with
PDTC for 1 h before treated with rPVL. Representative agarose-gel photographs showing the expression levels of IL-6 (A), IL-8 (B) and TNF-a (C) mRNA
in polymorphonuclear cells by RT-PCR analysis. The relative levels of IL-6 (D), IL-8 (E) and TNF-a (F) expressed in polymorphonuclear cells are shown.
Results represent the mean 6 SD of three separate measurements. * P,0.05.
doi:10.1371/journal.pone.0034970.g008
Figure 9. Lung histopathology of rabbits treated with PBS or rPVL. hematoxylin and eosin-stained sections (E–H; magnification 2006) from
the lungs of immunocompetent rabbits treated with PBS (A), rPVL (B), or from neutropenic rabbits treated with rPVL (C).
doi:10.1371/journal.pone.0034970.g009
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PLoS ONE | www.plosone.org 8 April 2012 | Volume 7 | Issue 4 | e34970Figure 10. Effect of rPVL on cytokine secretion. IL-6 (A), IL-8 (B), TNF-a (C), and IL-10 (D) from lung tissue homogenate was
measured by ELISA. Results shown are representative of two independent experiments. * P,0.05.
doi:10.1371/journal.pone.0034970.g010
Figure 11. Immunohistochemical staining of NF-kB in lung tissues. NF-kB is mainly expressed in the nucleus of neutrophils. A: Control group
negative for NF-kB; B: immunocompetent rabbits inoculated with rPVL; C: neutropenic rabbits inoculated with rPVL.
doi:10.1371/journal.pone.0034970.g011
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demonstrated that PVL could induce the transcription of a small
subset of NF-kB-regulated genes and subsequent TNF-a gene
expression in primary alveolar macrophages. Whether NF-kB
activation is associated with inflammatory cytokine release in
neutrophils is still unknown. The current study further investigated
the regulatory mechanisms of cytokine production in neutrophils.
Following treatment with rPVL, NF-kBp65 mRNA expression
increased obviously.Meanwhile, a higher expression level of NF-
kB protein in neutrophils compared with control groups showed
by Western blot analysis. Neutrophils were further incubated with
an NF-kB inhibitor (PDTC) to block its activation before rPVL
treatment. IL-6, IL-8 and TNF-a production significantly
decreased in the PDTC-pretreated group compared with the
PVL-treated group. These data suggested that PVL could induce
NF-kB, which is a prerequisite for inflammatory cytokine
synthesis.
Taken together, the data suggested that neutrophils might
damage lung tissue by secreting inflammatory cytokines, which
could be the primary cause of lung injury. To test this hypothesis,
rPVL was administered endotracheally into the lungs of
immunocompetent or neutropenic rabbits. The severity of
histopathology was increased in immunocompetent rabbits
compared with the control group (Figure 9D). rPVL-treated
animals exhibited increased inflammation with neutrophilic
infiltrate, necrosis, diffuse alveolar hemorrhage and pulmonary
edema. However, the lung tissues of neutropenic rabbits exhibited
mild or moderate inflammation. ELISA analysis also demonstrat-
ed that IL-6, IL-8 and TNF-a levels increased in the lungs of
immunocompetent rabbits compared with neutropenic rabbits
where there was no increase. The expression of NF-kB in the
animal models was analyzed by immunohistochemistry. NF-kB
expression in the lung tissues from neutropenic rabbits treated with
rPVL was significantly lower in the nucleus of cells compared with
the rPVL-treated immunocompetent rabbits.
This finding is consistent with a previous report that PVL can
induce acute lung injury and lung inflammation, rather than a
dependence upon bacterial survival or replication. Furthermore,
this suggests that neutrophils can amplify or perpetuate the acute
inflammatory response by release of pro-inflammatory cytokines,
which can recruit additional neutrophils into the inflamed lung.
Taken together, the data indicate that neutrophils are critical for
the development of PVL-induced lung inflammation and injury.
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